Boryung Corporation (KRX:003850)
South Korea · Delayed Price · Currency is KRW 9,730.00
+330.00 (3.51%)
Apr 8, 2026, 3:30 PM KST
Boryung Revenue
In the year 2025, Boryung had annual revenue of 1.02T KRW with 0.03% growth. Boryung had revenue of 245.35B in the quarter ending December 31, 2025, a decrease of -4.50%.
Revenue
1.02T
Revenue Growth
+0.03%
P/S Ratio
0.78
Revenue / Employee
663.68M
Employees
1,533
Market Cap
794.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.02T | 320.69M | 0.03% |
| Dec 31, 2024 | 1.02T | 157.48B | 18.32% |
| Dec 31, 2023 | 859.63B | 99.15B | 13.04% |
| Dec 31, 2022 | 760.48B | 133.20B | 21.23% |
| Dec 31, 2021 | 627.28B | 65.41B | 11.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.07T |
| Chong Kun Dang Pharmaceutical | 1.69T |
| Dong-A Socio Holdings | 1.43T |
| DongKook Pharmaceutical | 926.88B |
| Huons Global | 847.45B |
| Dong-A ST | 808.78B |
| JW Pharmaceutical | 775.30B |
| Ildong Pharmaceutical | 566.93B |